Roundtable: the future of AI in clinical research
We spoke to four leaders harnessing AI in clinical trials about its challenges and their vision for AI in the…
ByClinical Trials Arena
Innovation Fund Denmark: attracting investment in clinical trials
Innovation Fund Denmark invests in high-risk, high-potential innovation to improve the lives of the Danish population.
By
Telling the story: art’s potential to boost trial diversity
Lifeology is harnessing the art of visual storytelling to help fight mistrust and misinformation in the age of the ‘infodemic.’
By
Trial endpoints: is it time to get selective on surrogates?
Health policy professor Dr Huseyin Naci discusses the risks of leaning too hard on surrogate endpoints in clinical research.
By
How ketamine trials are providing a blueprint for suicidal ideation research
NIMH’s Dr Elizabeth Ballard discusses how ketamine has laid the groundwork for a new paradigm of suicide research.
By
Impressive early results for Vertex’s potentially curative stem cell diabetes therapy
A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin…
By
Remote communities of healthcare professionals are enabling DCTs
Hawthorne Effect’s Hero network is enabling continuous data capture in remote and hard to reach communities.
By
pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year’s end
The nasal spray is designed to offer hours of protection from a SARS-CoV-2 infection.
By